title: Topical bevacizumab therapy for corneal neovascularization.
authors.affiliation: Duke University Eye Center, Erwin Road, Box 3802, Durham, NC 27710, USA.
authors.forename: John J
authors.initials: JJ
authors.lastname: DeStafeno
authors.forename: Terry
authors.initials: T
authors.lastname: Kim
mesh_terms: D000287:Administration, Topical; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D016510:Corneal Neovascularization / Q000188:drug therapy*; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab